Best Practices for Preparation and Maintenance of Sponsor-Investigator INDs and IDEs

The BU Center for Future Technologies in Cancer Care and the BUMC Clinical Research Resources Office, in collaboration with the Duke Translational Medicine Institute (DTMI), are pleased to invite you to a special 2-part workshop on the FDA Investigational New Drug application (IND) and the Investigation Device Exemption application (IDE). The workshop is open to clinical researchers at Boston University and the New England Clinical Translational Science Institutes (CTSIs). Friday, October 11th 9am – 12noon: IND application process 1pm – 4pm IDE application process Registration https://bostonu.qualtrics.com/SE/?SID=SV_9SuaQ78v94lmeFv